Cargando…
Host Genetic Risk Factors for West Nile Virus Infection and Disease Progression
West Nile virus (WNV), a category B pathogen endemic in parts of Africa, Asia and Europe, emerged in North America in 1999, and spread rapidly across the continental U.S. Outcomes of infection with WNV range from asymptomatic to severe neuroinvasive disease manifested as encephalitis, paralysis, and...
Autores principales: | Bigham, Abigail W., Buckingham, Kati J., Husain, Sofia, Emond, Mary J., Bofferding, Kathryn M., Gildersleeve, Heidi, Rutherford, Ann, Astakhova, Natalia M., Perelygin, Andrey A., Busch, Michael P., Murray, Kristy O., Sejvar, James J., Green, Sharone, Kriesel, John, Brinton, Margo A., Bamshad, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174177/ https://www.ncbi.nlm.nih.gov/pubmed/21935451 http://dx.doi.org/10.1371/journal.pone.0024745 |
Ejemplares similares
-
Replication Cycle and Molecular Biology of the West Nile Virus
por: Brinton, Margo A.
Publicado: (2013) -
Clinical Manifestations and Outcomes of West Nile Virus Infection
por: Sejvar, James J.
Publicado: (2014) -
West Nile Virus–associated Flaccid Paralysis
por: Sejvar, James J., et al.
Publicado: (2005) -
West Nile Virus–associated Flaccid Paralysis Outcome
por: Sejvar, James J., et al.
Publicado: (2006) -
Arsenite-induced stress granule formation is inhibited by elevated levels of reduced glutathione in West Nile virus-infected cells
por: Basu, Mausumi, et al.
Publicado: (2017)